ADMA Biologics ADMA Occupancy and Related Charges
Occupancy and Related Charges at other companies
Other financials
Where this comes from
Reported directly by ADMA Biologics in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseExpense.
The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about ADMA Biologics's occupancy and related charges.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is ADMA Biologics's occupancy and related charges?
- ADMA Biologics (ADMA) reported occupancy and related charges of $500K in Q1 2026.
- How has ADMA Biologics's occupancy and related charges changed year-over-year?
- ADMA Biologics's occupancy and related charges decreased by 16.7% year-over-year, from $600K to $500K.
- What is the long-term trend for ADMA Biologics's occupancy and related charges?
- Over 2 years (2023 to 2025), ADMA Biologics's occupancy and related charges has grown at a 0.0% compound annual growth rate (CAGR), from $2.4M to $2.4M.
- What does occupancy and related charges mean?
- The total cost recognized in the income statement related to operating leases, typically representing the straight-line amortization of the right-of-use asset. It reflects the recurring operational cost of utilizing leased facilities or equipment.